Daratumumab induces mechanisms of immune activation through CD38+ NK cell targetingDomenico Viola(City of Hope), Flavia Pichiorri(City Of Hope National Medical Center)bioRxiv (Cold Spring Harbor Laboratory)November 22, 201910.1101/849265Cited by 9SaveCiteExport RISWatch citationsRelated PapersCD84 is a regulator of the immunosuppressive microenvironment in multiple myeloma|JCI Insight|2021|64HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide|Oncotarget|2015|43CD84 is a regulator of the immunosuppressive microenvironment in multiple myeloma|JCI Insight|2023|6